Paper40435995
TLR2 or TLR4 Stimulation Induces Transmembrane TNF-Driven Priming in Macrophages Which Results in Improved Clearance of a Subsequent Staphylococcus aureus Infection.
Luu AM and 7 others. J Innate Immun, 2025. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. TLR2 or TLR4 Stimulation Induces Transmembrane TNF-Driven Priming in Macrophages Which Results in Improved Clearance of a Subsequent Staphylococcus aureus Infection. Papers, record 40435995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40435995
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TLR2 or TLR4 Stimulation Induces Transmembrane TNF-Driven Priming in Macrophages Which Results in Improved Clearance of a Subsequent Staphylococcus aureus Infection.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Toll-Like Receptor 2 | Major topic |
| Staphylococcus aureus | Major topic |
| Staphylococcal Infections | Major topic |
| Toll-Like Receptor 4 | Major topic |
| Macrophages | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Animals | |
| Mice | |
| Mice, Knockout | |
| Mice, Inbred C57BL | |
| Cells, Cultured | |
| Macrophage Activation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 AI171903 | NIAID NIH HHS | United States | R21AI171903 | PubMed and NIH | NIH RePORTER |
| TL1 TR002318 | NCATS NIH HHS | United States | TL1TR002318 | PubMed and NIH | NIH RePORTER |
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26582142 | Dual transcriptome sequencing reveals resistance of TLR4 ligand-activated bone marrow-derived macrophages to inflammation mediated by the BET inhibitor JQ1. | Sci Rep | 2015 | https://conductscience.org/library/papers/26582142 | PubMed |
| 2 | 31363069 | Noncompetitive inhibitors of TNFR1 probe conformational activation states. | Sci Signal | 2019 | https://conductscience.org/library/papers/31363069 | PubMed |
| 3 | 11992285 | The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. | J Infect Dis | 2002 | https://conductscience.org/library/papers/11992285 | PubMed |
| 4 | 19448156 | Priming of alveolar macrophages upon instillation of lipopolysaccharide in the human lung. | Am J Respir Cell Mol Biol | 2010 | https://conductscience.org/library/papers/19448156 | PubMed |
| 5 | 29378181 | The E3 ubiquitin ligases HOIP and cIAP1 are recruited to the TNFR2 signaling complex and mediate TNFR2-induced canonical NF-κB signaling. | Biochem Pharmacol | 2018 | https://conductscience.org/library/papers/29378181 | PubMed |
| 6 | 23704210 | Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells. | Cancer Res | 2013 | https://conductscience.org/library/papers/23704210 | PubMed |
| 7 | 33270628 | Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2. | PLoS Biol | 2020 | https://conductscience.org/library/papers/33270628 | PubMed |
| 8 | 18161744 | Macrophage activation by endogenous danger signals. | J Pathol | 2008 | https://conductscience.org/library/papers/18161744 | PubMed |
| 9 | 25624856 | Tumor necrosis factor inhibitors - state of knowledge. | Arch Med Sci | 2014 | https://conductscience.org/library/papers/25624856 | PubMed |
| 10 | 23436141 | Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. | Mol Neurobiol | 2013 | https://conductscience.org/library/papers/23436141 | PubMed |
| 11 | 33986920 | Endothelial TLR2 promotes proangiogenic immune cell recruitment and tumor angiogenesis. | Sci Signal | 2021 | https://conductscience.org/library/papers/33986920 | PubMed |
| 12 | 28323513 | Transmembrane TNF-dependent uptake of anti-TNF antibodies. | MAbs | 2017 | https://conductscience.org/library/papers/28323513 | PubMed |
| 13 | 33336901 | Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/33336901 | PubMed |
| 14 | 15890966 | Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. | J Virol | 2005 | https://conductscience.org/library/papers/15890966 | PubMed |
| 15 | 30794556 | Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against bacterial infections. | PLoS One | 2019 | https://conductscience.org/library/papers/30794556 | PubMed |
| 16 | 7540941 | Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. | Immunity | 1995 | https://conductscience.org/library/papers/7540941 | PubMed |
| 17 | 33824270 | Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33824270 | PubMed |
| 18 | 24163075 | Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. | Am J Physiol Heart Circ Physiol | 2014 | https://conductscience.org/library/papers/24163075 | PubMed |
| 19 | 11117919 | Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. | Lancet | 2000 | https://conductscience.org/library/papers/11117919 | PubMed |
| 20 | 28431162 | Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis. | Rheumatology (Oxford) | 2018 | https://conductscience.org/library/papers/28431162 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41689830 | Editors' Choice 2025 <italic>Journal of Innate Immunity</italic>: From Receptor Proximal Training to Metabolic and Fibrotic Control. | J Innate Immun | 2026 | https://conductscience.org/library/papers/41689830 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40435995
GET https://conductscience.org/api/papers/v1/40435995/references?page=2